SMTL ID : 2hk5.1

Hck Kinase in Complex with Lck targetted Inhibitor PG-1009247

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 1BM: 3-{[2-(1H-BENZIMIDAZOL-1-YL)-6-{[2-(DIETHYLAMINO)ETHYL]AMINO}PYRIMIDIN-4-YL]AMINO}-4-METHYLPHENOL(Non-covalent)

1BM.1: 16 residues within 4Å: Chain A: L.23, V.31, A.43, K.45, E.60, M.64, I.86, T.88, F.90, M.91, G.94, A.140, N.141, L.143, A.153, D.154 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.23, A:L.23, A:K.45, A:K.45, A:I.86, A:T.88, A:F.90, A:L.143, A:A.153 Hydrogen bonds: A:E.60, A:T.88, A:M.91, A:D.154 Salt bridges: A:D.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sabat, M. et al., The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck). Bioorg.Med.Chem.Lett. (2006)

Release Date

2006-09-05

Peptides

Tyrosine-protein kinase HCK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase HCK